Vanguard Global Advisers’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Vanguard Global Advisers's PBYI Position: Q3 2026 in Review
Vanguard Global Advisers increased its Puma Biotechnology (PBYI) stake by 0.48% in Q3 2026, buying an estimated $1.94K and bringing the position to 46,487 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #2125.
Vanguard Global Advisers first reported a position in PBYI in Q1 2026 and has held it in 3 quarters since. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Vanguard Global Advisers held 46,487 shares of Puma Biotechnology worth $462K as of Q3 2026.
- Vanguard Global Advisers bought 220 Puma Biotechnology shares in Q3 2026, an estimated $1.94K.
- Puma Biotechnology made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2125 holding.
- Vanguard Global Advisers first reported a position in Puma Biotechnology in Q1 2026 and has held it in 3 quarters since.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.